Ohio State University doesn't have contracts tying building names to Les Wexner's donations

Ohio State University records show no formal contracts tying Les Wexner's name to building donations beyond honorific Board resolutions, though a 1987 agreement for the Wexner Center for the Arts documents Wexner paying more than $1 million, transferring roughly 100,000 shares of The Limited, and committing to top up contributions so total value equaled $15 million by 1997, including a $5 million earmark for the visual arts center (or estate-funded shortfall). Multiple survivor groups and the Ohio Nurses Association are seeking removal of Wexner's name from the Wexner Medical Center and Les Wexner Football Complex after DOJ documents linked him as a co-conspirator in the Epstein probe, presenting reputational and governance risk for the university even though Wexner has not been charged.

Analysis

Market structure: This is primarily a reputational/governance shock concentrated in higher-education and large-healthcare systems with high-profile donors. Direct beneficiaries in the near term are legal advisers, crisis-PR/rebranding firms, and liability insurers who will see incremental demand (+5–20% fee opportunity over 3–12 months); losers are university brands, legacy-named assets, and any balance sheets that must absorb settlement or rebranding costs. Pricing power shifts toward specialist advisers; universities may accelerate contractual clarifications on naming rights which increases short-term legal spend and reduces long-term donor optionality.

Risk assessment: Tail risks include a major settlement or chain reaction of donor withdrawals that increases a large public university’s credit spreads by >100bps and forces budget reallocation; probability low but impact material to single-name muni holders. Immediate (days–weeks) risk is reputational contagion and activist pressure; short-term (weeks–months) risk is litigation filings or trustee decisions; long-term (quarters–years) is structural tightening of donor contracts and reduced large gifts (10–30% decline for at-risk donors). Hidden dependencies include indemnity clauses, estate obligations, and insurer sublimits that can shift costs off-balance-sheet.

Trade implications: Favor equities of crisis advisory and rebranding beneficiaries (public: FCN, OMC) and defensive healthcare operators with strong governance (UNH, HCA) while avoiding long-dated, single-name university muni exposures. Options: purchase 3-month call spreads on FCN/OMC to capture fee-driven upside while capping cost. Monitor OSU trustee votes, DOJ/oversight releases, and any announced settlements within 30–90 days as primary catalysts that will move muni spreads and advisor revenues.

Key Decisions for Investors

• Establish a 1–1.5% portfolio long split between FTI Consulting (FCN) and Omnicom (OMC) (0.5–0.75% each) with a 3–9 month horizon; target entry on ≤5% pullback and sell into a 20–35% rally.
• Add 1% long positions in UnitedHealth (UNH) and HCA Healthcare (HCA) (0.5% each) as defensive healthcare exposure; enter on any >3% market dip and hold 6–12 months to capture stable cash flows amid reputational rotations.
• Reduce concentration in single-issuer/university muni holdings: trim long-dated exposure by 15–25% if OSU-related spreads widen >25bps vs MMD, or if trustees announce litigation/settlements; redeploy into broad muni ETF (MUB) with shorter duration.
• Buy 3-month call spreads on FCN and OMC sized at 0.25–0.5% AUM each (buy ~5% ITM–sell ~15% OTM strikes) to capture accelerated advisory fee upside while capping premium; roll or exit on catalyst events within 90 days.
• Within the next 30 days, monitor OSU Board minutes, DOJ/oversight document releases, and any large settlement announcements. If trustees reject renaming but litigation escalates, rotate 0.5–1% from equities into short-duration municipal credit to hedge single-institution tail risk.